Posts Tagged ‘Avandia’

Experts urge US to restrict drug Avandia
A majority of members of a key advisory committee have recommended that the US government allow diabetes drug Avandia to stay on the market with greater restrictions on its sale.

Avandia On Trial: Glaxo’s Defense III
More on the FDA panel that could decide the diabetes drug’s fate.

Avandia Heart Risks Buried by Drug Company: Report
Report shows diabetes drug maker knew 11 years ago that Avandia caused heart problems.

Avandia: Is it too risky to take?
A review by federal health scientists reinforces potential ties between the diabetes pill Avandia and heart attack and death, opening the door for government action, including a possible withdrawal of the once blockbuster drug. Diabetes mellitus – Health – Conditions and Diseases – Rosiglitazone – Pharmaceutical drug

Avandia Put to Test By FDA Committee
After years of controversy, the Food and Drug Administration is gearing up to decide the fate of popular diabetes drug, Avandia. An FDA advisory panel of experts will meet next week to weigh the evidence against Avandia and make a recommendation as to whether the GlaxoSmithKline drug poses cardiovascular risk to patients and should be pulled from the market. GlaxoSmithKline – Food and Drug …

FDA to look at the safety of Avandia
The arthritis pill Vioxx was withdrawn, but menopause hormones were not, even though both were tied to heart risks. A multiple sclerosis medicine was pulled and later allowed back on the market.

The Case Against Avandia Mounts
Two more studies raise safety questions about a once-popular diabetes drug. Advisers to the Food and Drug Administration will weigh the evidence in July.

Q+A-Does Avandia damage the heart? Questions remain
WASHINGTON, June 28 (Reuters) – Two studies released on Monday show GlaxoSmithKline Plc diabetes pill Avandia may damage the heart, adding to pressure on U.S. regulators deciding whether the drug should stay on the market. [ID:nN28257505 ]

(AFX UK Focus) 2010-06-28 19:22 Q+A-Does Avandia damage the heart? Questions remain
WASHINGTON, June 28 (Reuters) – Two studies released on Monday show GlaxoSmithKline Plc diabetes pill Avandia may damage the heart, adding to pressure on U.S. regulators deciding whether the drug should stay on the market. Here are some questions and answers about the issues surrounding Avandia, which is still a blockbuster drug, with $1.2 billion in sales in 2009.

Safety worries over Glaxo’s Avandia diabetes drug
WASHINGTON, Feb 21 – Two US drug safety reviewers have recommended that GlaxoSmithKline PLC’s diabetes drug Avandia be pulled from the market after concluding it is more dangerous to the heart than a rival medicine, according to documents released on Saturday. The Food and Drug Administration will again ask an advisory panel to consider the risks of the drug, Glaxo’s second biggest-selling …